130 related articles for article (PubMed ID: 38151767)
1. Lumbar vertebral bone density is decreased in horses with pituitary pars intermedia dysfunction.
Colbath AC; Fortin JS; Burglass CM; Panek C; Vergara-Hernandez FB; Johnson TN; Robison CA; Logan AA; Nelson NA; Nielsen BD; Schott HC
Equine Vet J; 2024 Mar; 56(2):368-376. PubMed ID: 38151767
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of equine pituitary pars intermedia dysfunction.
Stewart AJ; Ireland JL; Durham AE; McGowan CM
Vet J; 2023; 300-302():106036. PubMed ID: 37805159
[TBL] [Abstract][Full Text] [Related]
3. BEVA primary care clinical guidelines: Diagnosis and management of equine pituitary pars intermedia dysfunction.
Menzies-Gow NJ; Banse HE; Duff A; Hart N; Ireland JL; Knowles EJ; McFarlane D; Rendle D
Equine Vet J; 2024 Mar; 56(2):220-242. PubMed ID: 37795557
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of seasonal influences on adrenocorticotropic hormone response to the thyrotropin-releasing hormone stimulation test and its accuracy for diagnosis of pituitary pars intermedia dysfunction.
Adams AA; Siard-Altman MH; Reedy SE; Barker D; Elzinga S; Sanz MG; Urschel K; Ireland JL
Vet J; 2023; 300-302():106035. PubMed ID: 37802466
[TBL] [Abstract][Full Text] [Related]
5. PITUITARY PARS INTERMEDIA DYSFUNCTION (EQUINE CUSHING'S DISEASE) IN NONDOMESTIC EQUIDS AT MARWELL WILDLIFE: A CASE SERIES. ONE CHAPMAN'S ZEBRA ( EQUUS QUAGGA CHAPMANI) AND FIVE PRZEWALSKI's HORSES ( EQUUS FERUS PRZEWALSKII).
Shotton JCR; Justice WSM; Salguero FJ; Stevens A; Bacci B
J Zoo Wildl Med; 2018 Jun; 49(2):404-411. PubMed ID: 29900762
[TBL] [Abstract][Full Text] [Related]
6. Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction.
Fortin JS; Benskey MJ; Lookingland KJ; Patterson JS; Howey EB; Goudreau JL; Schott HC
BMC Vet Res; 2020 Sep; 16(1):356. PubMed ID: 32977825
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting measurement of basal adrenocorticotropic hormone in adult domestic equids: A scoping review.
Ireland JL; Lester A; Banse HE
Vet J; 2024 Apr; 304():106071. PubMed ID: 38341024
[TBL] [Abstract][Full Text] [Related]
8. Computed tomographic findings in the pituitary gland and brain of horses with pituitary pars intermedia dysfunction.
Pease AP; Schott HC; Howey EB; Patterson JS
J Vet Intern Med; 2011; 25(5):1144-51. PubMed ID: 21985144
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction.
Horn R; Bamford NJ; Afonso T; Sutherland M; Buckerfield J; Tan RHH; Secombe CJ; Stewart AJ; Bertin FR
Equine Vet J; 2019 Jul; 51(4):440-445. PubMed ID: 30417404
[TBL] [Abstract][Full Text] [Related]
10. Cytokine dysregulation in aged horses and horses with pituitary pars intermedia dysfunction.
McFarlane D; Holbrook TC
J Vet Intern Med; 2008; 22(2):436-42. PubMed ID: 18371032
[TBL] [Abstract][Full Text] [Related]
11. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
Beech J; Boston R; Lindborg S; Russell GE
J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
[TBL] [Abstract][Full Text] [Related]
12. What's New in Old Horses? Postmortem Diagnoses in Mature and Aged Equids.
Miller MA; Moore GE; Bertin FR; Kritchevsky JE
Vet Pathol; 2016 Mar; 53(2):390-8. PubMed ID: 26459516
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses.
McGowan TW; Pinchbeck GP; McGowan CM
Equine Vet J; 2013 Jan; 45(1):74-9. PubMed ID: 22594955
[TBL] [Abstract][Full Text] [Related]
14. Lamellar pathology in horses with pituitary pars intermedia dysfunction.
Karikoski NP; Patterson-Kane JC; Singer ER; McFarlane D; McGowan CM
Equine Vet J; 2016 Jul; 48(4):472-8. PubMed ID: 25869529
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hair follicle histology between horses with pituitary pars intermedia dysfunction and excessive hair growth and normal aged horses.
InnerĂ¥ M; Petersen AD; Desjardins DR; Steficek BA; Rosser EJ; Schott HC
Vet Dermatol; 2013 Feb; 24(1):212-7.e46-7. PubMed ID: 23331700
[TBL] [Abstract][Full Text] [Related]
16. Investigation of rhythms of secretion and repeatability of plasma adrenocorticotropic hormone concentrations in healthy horses and horses with pituitary pars intermedia dysfunction.
Rendle DI; Litchfield E; Heller J; Hughes KJ
Equine Vet J; 2014 Jan; 46(1):113-7. PubMed ID: 23742059
[TBL] [Abstract][Full Text] [Related]
17. Dermatitis, cellulitis, and osteomyelitis caused by
Waitt Wolker LH; Black A; Lee JK
J Vet Diagn Invest; 2024 Mar; 36(2):248-253. PubMed ID: 38462742
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses.
Horn R; Bertin FR
J Vet Intern Med; 2019 Sep; 33(5):2249-2256. PubMed ID: 31498947
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of dynamic testing for pituitary pars intermedia dysfunction diagnosis in donkeys.
Mejia-Pereira S; Perez-Ecija A; Buchanan BR; Toribio RE; Mendoza FJ
Equine Vet J; 2019 Jul; 51(4):481-488. PubMed ID: 30362589
[TBL] [Abstract][Full Text] [Related]
20. Short-Term Effects of Temperature and Thyrotropin-Releasing Hormone Stimulation on Adrenocorticotropin Stability in Horses.
Hinrichsen SL; Yuen KY; Dryburgh EL; Bertin FR; Stewart AJ
Animals (Basel); 2022 Jan; 12(3):. PubMed ID: 35158648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]